File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Treatment strategy for recurrent hepatocellular carcinoma: salvage liver transplantation, repeated hepatic resection, or radiofrequency ablation

TitleTreatment strategy for recurrent hepatocellular carcinoma: salvage liver transplantation, repeated hepatic resection, or radiofrequency ablation
Authors
Chan, ACYChan, SCChok, KSHCheung, TTSharr, WDai, JFan, STLo, CM
KeywordsMedical sciences
Gastroenterology medical sciences
Surgery
Issue Date2012
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jtoc/106570021
Citation
The 18th Annual International Congress of the International Liver Transplantation Society (ILTS 2012), San Francisco, CA., 12-15 May 2012. In Liver Transplantation, 2012, v. 18 suppl. S1, p. S134, abstract O-157 How to Cite?
DOI: http://dx.doi.org/10.1002/lt.23435
AbstractINTRODUCTION: The best treatment strategy for recurrent hepatocellular carcinoma(rHCC) remains poorly defined. The purpose of this study is to compare the efficacy of salvage liver transplantation (SLT), repeated hepatic resection (RHR) and radiofrequency ablation(RFA) in patients with intrahepatic recurrence after treatment of primary HCC within Milan criteria, so as to define an efficacious treatment algorithm for this disease entity. METHODS: From June 1997 and June 2010, 504 patients received either hepatic resections or RFA for primary HCC within Milan criteria in our center. In all, 186 patients (37.4%) developed intrahepatic recurrences and 92 of them were selected for SLT (n=19), RHR(n=25) or RFA(n=48). Their clinicopathological data and survival outcomes were reviewed. Survival curves were plotted by Kaplan Meier ...
DescriptionOral Presentation - Interactive Concurrent Session 4: HCC Salvage Transplant vs. LDLT vs. Cadaveric OLT: abstract no. O-157
This journal suppl. entitled: Supplement: The ILTS 18th Annual International Congress
Persistent Identifierhttp://hdl.handle.net/10722/165662
ISSN
1527-6465
2021 Impact Factor: 6.112
2020 SCImago Journal Rankings: 1.814

 

DC FieldValueLanguage
dc.contributor.authorChan, ACYen_US
dc.contributor.authorChan, SC-
dc.contributor.authorChok, KSH-
dc.contributor.authorCheung, TT-
dc.contributor.authorSharr, W-
dc.contributor.authorDai, J-
dc.contributor.authorFan, ST-
dc.contributor.authorLo, CM-
dc.date.accessioned2012-09-20T08:21:43Z-
dc.date.available2012-09-20T08:21:43Z-
dc.date.issued2012en_US
dc.identifier.citationThe 18th Annual International Congress of the International Liver Transplantation Society (ILTS 2012), San Francisco, CA., 12-15 May 2012. In Liver Transplantation, 2012, v. 18 suppl. S1, p. S134, abstract O-157en_US
dc.identifier.issn1527-6465-
dc.identifier.urihttp://hdl.handle.net/10722/165662-
dc.descriptionOral Presentation - Interactive Concurrent Session 4: HCC Salvage Transplant vs. LDLT vs. Cadaveric OLT: abstract no. O-157-
dc.descriptionThis journal suppl. entitled: Supplement: The ILTS 18th Annual International Congress-
dc.description.abstractINTRODUCTION: The best treatment strategy for recurrent hepatocellular carcinoma(rHCC) remains poorly defined. The purpose of this study is to compare the efficacy of salvage liver transplantation (SLT), repeated hepatic resection (RHR) and radiofrequency ablation(RFA) in patients with intrahepatic recurrence after treatment of primary HCC within Milan criteria, so as to define an efficacious treatment algorithm for this disease entity. METHODS: From June 1997 and June 2010, 504 patients received either hepatic resections or RFA for primary HCC within Milan criteria in our center. In all, 186 patients (37.4%) developed intrahepatic recurrences and 92 of them were selected for SLT (n=19), RHR(n=25) or RFA(n=48). Their clinicopathological data and survival outcomes were reviewed. Survival curves were plotted by Kaplan Meier ...-
dc.languageengen_US
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jtoc/106570021-
dc.relation.ispartofLiver Transplantationen_US
dc.rightsLiver Transplantation. Copyright © John Wiley & Sons, Inc.-
dc.subjectMedical sciences-
dc.subjectGastroenterology medical sciences-
dc.subjectSurgery-
dc.titleTreatment strategy for recurrent hepatocellular carcinoma: salvage liver transplantation, repeated hepatic resection, or radiofrequency ablationen_US
dc.typeConference_Paperen_US
dc.identifier.emailChan, ACY: acchan@hku.hken_US
dc.identifier.emailChan, SC: chanlsc@hku.hk-
dc.identifier.emailChok, KSH: chok6275@hku.hk-
dc.identifier.emailSharr, W: wwsharr@hku.hk-
dc.identifier.emailFan, ST: stfan@hku.hk-
dc.identifier.emailLo, CM: chungmlo@hkucc.hku.hk-
dc.identifier.authorityChan, ACY=rp00310en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1002/lt.23435-
dc.identifier.hkuros211467en_US
dc.identifier.volume18-
dc.identifier.issuesuppl. S1-
dc.identifier.spageS134, abstract O-157-
dc.identifier.epageS134, abstract O-157-
dc.publisher.placeUnited States-
dc.customcontrol.immutablesml 140704-
dc.identifier.issnl1527-6465-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats